Non classé
Do You Want to Have a Say in which Treatments Will Be Available in EU Countries? Get involved in EU HTA
HTA Regulation will involve patients in joint technology assessments at the EU level for oncology treatments. This will utilise patients’ kno...
Reflecting on a Milestone: The Successful Romanian Policy Event on Digestive Cancers
June 2, 2024 – The recent Romanian policy event on digestive cancers, held on May 28, has left us with a sense of profound accomplishment and...
United Against Pancreatic Cancer: A Call to Action Ahead of the 2024 EU Elections
In anticipation of the upcoming 2024 EU Elections, we are supporting Pancreatic Cancer Europe’s (PCE) initiative to turn the tide against pan...
DiCE Highlights the Need for Timely Access to Medicines at the 20th Biosimilars Conference in Amsterdam
We were glad to contribute to the discussions on the best ways to future-proof access to the next wave of cancer medicines. DiCE participated in a ...
DiCE’s Report from the EASL Liver Cancer Summit
The EASL | The Home of Hepatology Liver Cancer Summit took place in Rotterdam, The Netherlands, from 22 – 24 February. This annual meeting i...
Lynch Syndrome and the Challenge of Getting a Diagnosis
Lynch Syndrome, also known as hereditary nonpolyposis colorectal cancer (HNPCC), is a hereditary condition characterised by a high risk of various ...
Europacolon Portugal Successfully Implements Pilot Project
The ‘+INTESTINO’ initiative, held from 16 – 27 October marked a significant step in promoting health and raising awareness about bowel ca...
Beating Cancer Inequalities in the EU – An OECD Report Summary
Cancer is a significant health problem in Europe. It is estimated that every 5 minutes, a person is diagnosed with a type of cancer. It is expected...
European Commission is Looking for Experts in CRC
European Commission is looking for experts in CRC (pathology, radiation oncology and nursing). Deadline: 8 March 2024
...
Biomarkers and their Role in the Diagnosis and Treatment of Cholangiocarcinoma (CCA)
Researchers in Italy have written a helpful and very detailed review of biomarkers specific to iCCA. Biomarkers are measurable medical signs that c...